Evidence map›Paper›PMID 41970095›Full record

ArticleCureus2026

Mild Encephalitis/Encephalopathy With a Reversible Splenial Lesion of the Corpus Callosum (MERS): A Report of Two Pediatric Cases.

Amine Kaake

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Amine KaakePediatric Neurology, Hôpital Robert-Debré, AP-HP, Paris, FRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mild encephalitis/encephalopathy with a reversible splenial lesion of the corpus callosum (MERS) is an uncommon clinico-radiological syndrome marked by transient lesions of the splenium, which are typically demonstrated as diffusion-restricted hyperintensities on MRI. It presents with acute neurological symptoms such as seizures, dysarthria, or ataxia, often following viral infections. We report two pediatric cases of MERS observed in the ED. The first was a 23-month-old boy with focal status epilepticus in the setting of acute gastroenteritis. The second was an eight-year-old boy who presented with dysarthria, gait ataxia, and sensorimotor deficits after a febrile viral illness. Brain MRI in both patients showed diffusion-restricted lesions in the splenium of the corpus callosum, with no contrast enhancement. CSF and infectious workups were unremarkable, except for positive respiratory viral PCR in one case. Neurological recovery was rapid and complete in both children. Follow-up MRIs demonstrated full resolution of the lesions. These clinical and radiological patterns confirmed the diagnosis of MERS. These cases highlight the importance of recognizing MERS as a reversible and self-limiting cause of pediatric encephalopathy. Early MRI is crucial for diagnosis, avoiding unnecessary interventions, and guiding supportive management. Awareness of MERS and its typical imaging features is essential for clinicians and radiologists dealing with pediatric neurological presentations.

Indexed as

mersmild encephalopathy/aseptic encephalitis with reversible splenial lesion of the corpus callosumneurology and pediatric neurologyreversible splenial lesion syndromeviral encephalopathy

Identifiers

PMID41970095
PMCPMC13062467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.